Anti-inflammatory and anti-oxidative effects of Ganoderma lucidum on liver injury induced by doxorubicin in rats

authors:

avatar Reza Hemmatan Atarbashi , avatar Amir RezaKaramibonari , * , avatar Tarlan Farahvash

Koomesh: Vol.25, issue 3; 289-298
published online: July 02, 2023
article type: Research Article
received: July 02, 2022
accepted: July 02, 2023

how to cite: Hemmatan Atarbashi R, RezaKaramibonari A, Farahvash T. Anti-inflammatory and anti-oxidative effects of Ganoderma lucidum on liver injury induced by doxorubicin in rats. koomesh. 2023;25(3):e152827. 

Abstract

Introduction: Natural products have recently been used as alternative treatments for many diseases. This study aimed to determine the hepatoprotective effect of Ganoderma lucidum (GLE) against liver injury induced by   Doxorubicin (DOX). Materials and Methods: Thirty – two male Wistar rats were randomly divided into four groups. The control group was given only saline by intragastric gavage. DOX group received DOX at the dose of 20 mg/kg intraperitoneally on day 2. The GLE group was given an aqueous extract of GLE at the dose of 500 mg/kg daily by intragastric gavage for 15 days. DOX-GLE group received DOX and GLE with the same protocol as DOX and GLE groups. Results: In this study, a significant increase in Tumor necrosis factor alpha (TNF-α) expression and Malondialdehyde (MDA) level in the liver and a significant decrease in the levels of Superoxide dismutase (SOD), Glutathione peroxidase (GPX) and total antioxidant capacity (TAC) in serum were observed in rats that received DOX when compared with the control group. A significant decrease in TNF-α expression and MDA level and a significant increase in the levels of SOD, GPX, and TAC in serum and liver tissue were observed in rats that received GLE with DOX when compared with DOX group (P<0.05). Conclusion: It is remarkable to say that, the DOX could induce marked toxicity in the liver, and treatment with GLE produced potential improvement of the liver via repression of oxidative stress and inflammatory responses.

References

  • 1.

    Andrejc DC, Knez Z, Marevci MK. Antioxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: An overview. Front Pharmacol 2022; 2757.

  • 2.

    Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chemic Pharmac Bulletin 2002; 50: 837-840.

  • 3.

    Hu Z, Du R, Xiu L, Bian Z, Ma C, Sato N, et al. Protective effect of triterpenes of Ganoderma lucidum on lipopolysaccharide-induced inflammatory responses and acute liver injury. Cytokine 2020; 127: 154917.

  • 4.

    Liu GQ, Zhang KC. Mechanisms of the anticancer action of Ganoderma lucidum (Leyss. ex Fr.) Karst. a new understanding. Integrative Plant Bio 2005; 47: 129-135.##https://doi.org/10.1111/j.1744-7909.2005.00037.x.

  • 5.

    Wang YY, Khoo KH, Chen ST, Lin CC, Wong CH, Lin CH. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorganic Med Chem 2002; 10: 1057-1062.

  • 6.

    El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochem 1998; 49: 1651-1657.

  • 7.

    Fang QH, Tang YJ, Zhong JJ. Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochem 2002; 37: 1375-1379.

  • 8.

    Su CY, Shiao MS, Wang CT. Potentiation of ganodermic acid S on prostaglandin E1-induced cyclic AMP elevation in human platelets. Thrombosis Res 2000; 99: 135-145.

  • 9.

    Saltarelli R, Ceccaroli P, Iotti M, Zambonelli A, Buffalini M, Casadei L, et al. Biochemical characterisation and antioxidant activity of mycelium of Ganoderma lucidum from Central Italy. Food Chem 2009; 116: 143-151.##https://doi.org/10.1016/j.foodchem.2009.02.023.

  • 10.

    Lin WC, Lin WL. Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. Gastroenterology 2006; 12: 265.

  • 11.

    Park EJ, Ko G, Kim J, Sohn DH. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull 1997; 20: 417-420.

  • 12.

    Ahmed OM, Galaly SR, Raslan M, Mostafa MA. Thyme oil and thymol abrogate doxorubicin-induced nephrotoxicity and cardiotoxicity in Wistar rats via repression of oxidative stress and enhancement of antioxidant defense mechanisms. Biocell 2020; 44: 41.##https://doi.org/10.32604/biocell.2020.08157.

  • 13.

    Shamsi F. Nanotechnology application in cancer treatment. Koomesh 2019; 21: 579-589. (Persian).

  • 14.

    Shahani S, Sahranavard M, Amiri F, Abedi M, Noaparast Z. Beneficial effects of Pimpinella anisum L. ethanol and aqueous extracts on L-asparaginase-associated hepatotoxicity using specific 99mTc-Phytate biodistribution studies in rats. Koomesh 2022; 24: 554-565. (Persian).

  • 15.

    El-Moselhy MA, El-Sheikh AA. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity. Biomed Pharmacother 2014; 68: 101-110.

  • 16.

    Altnkaynak Y, Kural B, Akcan BA, Bodur A, zer S, Yulu E, et al. Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats. Biomed Pharmacother 2018; 108: 1524-1534.

  • 17.

    Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004; 348: 27-34.

  • 18.

    Kuzu M, Yldrm S, Kandemir FM, Kkler S, alayan C, Trk E, et al. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats. Chem Biol Interact 2019; 308: 89-100.

  • 19.

    Hadi N, Yousif NG, Al-Amran FG, Huntei NK, Mohammad BI, Ali SJ. Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response. BMC Cardiovas Dis 2012; 12: 1-7.

  • 20.

    Fathima AT, Reenaa M. Anticancer and antibacterial activity of ganoderma lucidum. Int J Curr Microbiol App Sci 2016; 5: 891-909.##https://doi.org/10.20546/ijcmas.2016.510.097.

  • 21.

    Hassan HM, Al-Wahaibi LH, Elmorsy MA, Mahran YF. Suppression of cisplatin-induced hepatic injury in rats through alarmin high-mobility group box-1 pathway by Ganoderma lucidum: theoretical and experimental study. Drug Des Dev Ther 2020; 14: 2335.

  • 22.

    Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278.

  • 23.

    Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.

  • 24.

    Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarenon D, et al. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004; 5: 1-0.

  • 25.

    Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Biol Med 2012; 52: 59-69.

  • 26.

    Al-Oanzi ZH, Elasbali AM, Alruwaili NK, Alotaibi NH, Alharbi KS, Alzarea AI, et al. Protective effect of baicalein alone and losartan-baicalein combination therapy on doxorubicin-induced hepatotoxicity in rats. Toxicol Environ Health Sci 2020; 12: 45-54.##https://doi.org/10.1007/s13530-020-00037-7.

  • 27.

    Shaker RA, Abboud SH, Assad HC, Hadi N. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. BMC Pharmacother Toxicol 2018; 19: 3.

  • 28.

    Saltarelli R, Ceccaroli P, Iotti M, Zambonelli A, Buffalini M, Casadei L, et al. Biochemical characterisation and antioxidant activity of mycelium of Ganoderma lucidum from Central Italy. Food Chem 2009; 116: 143-151.##https://doi.org/10.1016/j.foodchem.2009.02.023.

  • 29.

    Fernandez ML, West KL. Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr 2005; 135: 2075-2078.

  • 30.

    Lin LJ, Shiao MS, Yeh SF. Seven new triterpenes from Ganoderma lucidum. J Nat Prod 1988; 51: 918-924.

  • 31.

    Tulubas F, Gurel A, Oran M, Topcu B, Caglar V, Uygur E. The protective effects of -3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats. Toxicol Ind Health 2015; 31: 638-644.

  • 32.

    Hirotani M, Ino C, Furuya T, Shiro M. Ganoderic acids T, S and R. New triterpenoids from the cultured mycelia of Ganoderma lucidum. Chem Pharm Bull 1986; 34: 2282-2285.##https://doi.org/10.1248/cpb.34.2282.

  • 33.

    Hossen M, Billah Prince M, Tanvir EM, Chowdhury M, Rahman M, Alam F, et al. Ganoderma lucidum and Auricularia polytricha mushrooms protect against Carbofuran-induced toxicity in rats. Evi Based Complement Alternat Med 2018; 2018.

  • 34.

    Susilo RJ, Winarni D, Husen SA, Hayaza S, Punnapayak H, Wahyuningsih SP, et al. Hepatoprotective effect of crude polysaccharides extracted from Ganoderma lucidum against carbon tetrachloride-induced liver injury in mice. Vet World 2019; 12: 1987.